Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21,009 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma.
Yang DH, Min JJ, Jeong YY, Ahn JS, Kim YK, Cho SH, Chung IJ, Bom HS, Kim HJ, Lee JJ. Yang DH, et al. Among authors: kim yk, kim hj. Ann Hematol. 2009 May;88(5):425-32. doi: 10.1007/s00277-008-0616-3. Epub 2008 Nov 12. Ann Hematol. 2009. PMID: 19002686 Clinical Trial.
Polymyositis and myocarditis after donor lymphocyte infusion.
Ahn JS, Cho SH, Kim YK, Yang DH, Bae WK, Shim HJ, Lee JJ, Chung IJ, Juhng SW, Kim HJ. Ahn JS, et al. Among authors: kim yk, kim hj. Int J Hematol. 2009 Jul;90(1):113-116. doi: 10.1007/s12185-009-0332-3. Epub 2009 May 27. Int J Hematol. 2009. PMID: 19472035
Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study.
Kim YK, Sohn SK, Lee JH, Yang DH, Moon JH, Ahn JS, Kim HJ, Lee JJ; Korean Multiple Myeloma Working Party (KMMWP). Kim YK, et al. Among authors: kim hj. Ann Hematol. 2010 May;89(5):475-82. doi: 10.1007/s00277-009-0856-x. Epub 2009 Nov 18. Ann Hematol. 2010. PMID: 19921192 Clinical Trial.
Induction treatment with cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma: a phase II study.
Yang DH, Kim YK, Sohn SK, Chung JS, Joo YD, Lee JH, Lee JL, Ahn JS, Moon JH, Shin HJ, Choi YJ, Lee WS, Kim HJ, Lee JJ; Korean Multiple Myeloma Working Party. Yang DH, et al. Among authors: kim yk, kim hj. Clin Lymphoma Myeloma Leuk. 2010 Feb;10(1):62-7. doi: 10.3816/CLML.2010.n.007. Clin Lymphoma Myeloma Leuk. 2010. PMID: 20223731 Clinical Trial.
Coexisting with clonal evolution and BCR-ABL mutant in CML patients treated with second-generation tyrosine kinase inhibitors predict the discrepancy of in vitro drug sensitivity.
Ahn JS, Kim YK, Lee SR, Yu L, Yang DH, Cho SH, Shim HJ, Bae WK, Lee JJ, Chung IJ, Shin MG, Kim HJ. Ahn JS, et al. Among authors: kim yk, kim hj. Cancer Res Treat. 2010 Mar;42(1):37-41. doi: 10.4143/crt.2010.42.1.37. Epub 2010 Mar 31. Cancer Res Treat. 2010. PMID: 20369050 Free PMC article.
21,009 results
You have reached the last available page of results. Please see the User Guide for more information.